An observational study in Diplegic Spastic Cerebral Palsy, sponsored by Cairo University. Active, not recruiting at 1 site in Egypt. Open to participants aged 6 Years to 8 Years. Per ClinicalTrials.gov, last updated 2025-04-09.
Sponsored by Cairo University · Observational
The hip extensors are essential for upright posture and forward propulsion during gait. Children with diplegic CP often demonstrate reduced muscle strength, which impacts their gait speed and overall mobility. Understanding the relationship between hip extensor strength and gait speed could provide a basis for targeted interventions. This feasibility study will establish whether the handheld dynamometer can reliably measure hip extensor strength and if this strength correlates with gait speed in children with diplegic CP.
1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.
This study's planned enrollment of 20 is below the median of 63 across 455 observational studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Children with diplegic CP who can walk
Diagnosed with diplegic CP
Exclusion Criteria:
Severe cognitive or behavioral impairments affecting participation
Diagnostic Test: Lafayette
The Lafayette handheld dynamometer data correlates with the measurements taken using the 10-Meter Walk Test (10MWT) or not.
Lafayette handheld dynamometer.
Hip Extensor Strength
Hip extensor strength measured using a Lafayette handheld dynamometer.
Time frame: 4 months
This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University